A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Can

clinical trial

A Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-resistant Prostate Cancer and Men With Metastatic Prostate Can is …
instance of (P31):
clinical trialQ30612

External links are
P3098ClinicalTrials.gov IDNCT02066961

P17countrySpainQ29
CanadaQ16
ItalyQ38
NetherlandsQ55
MexicoQ96
EgyptQ79
BrazilQ155
GermanyQ183
SingaporeQ334
FranceQ142
IndonesiaQ252
ArgentinaQ414
AlgeriaQ262
AustraliaQ408
New ZealandQ664
PeruQ419
IsraelQ801
United KingdomQ145
AustriaQ40
ColombiaQ739
LebanonQ822
OmanQ842
Saudi ArabiaQ851
TaiwanQ865
ThailandQ869
PhilippinesQ928
P582end time2019-11-01
P921main subjectmetastatic prostate carcinomaQ55779807
P1132number of participants1533
P1813short nameASPIRE-PCa
P580start time2013-12-31
P8363study typeobservational studyQ818574
P1476titleA Prospective, Longitudinal, Multinational, Observational Study to Describe Patterns of Care and Outcomes of Men Who Are at High Risk for Poor Clinical Outcomes After Experiencing Biochemical Failure Following Definitive Prostate Cancer Therapy, Men With Castration-Resistant Prostate Cancer and Men With Metastatic Prostate Cancer at Initial Diagnosis